ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,279Medicare Part D Prescriptions Filled, Including Refills

Rank: 100 out of 2604

$564K Total Retail Price of All Prescriptions

Rank: 145 out of 2604

420 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 420 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 420 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 7,723 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LISINOPRIL 392 327 1 3
HYDROCODONE-ACETAMINOPHEN 389 299 S3 2 1
FUROSEMIDE 347 298 3 8
LEVOTHYROXINE SODIUM 326 282 4 4
OMEPRAZOLE 306 219 5 5
DONEPEZIL HCL 238 229 6 28
SIMVASTATIN 234 205 7 2
AMLODIPINE BESYLATE 232 202 8 6
CITALOPRAM HBR 217 187 9 18
POTASSIUM CHLORIDE 204 166 10 16
METOPROLOL TARTRATE 186 154 11 9
METFORMIN HCL 169 125 12 7
RISPERIDONE 155 125 13 65
NAMENDA 148 125 14 37
WARFARIN SODIUM 137 94 15 13
ATENOLOL 135 96 16 11
GABAPENTIN 127 102 17 12
QUETIAPINE FUMARATE 124 100 18 66
CARVEDILOL 120 108 19 26
FENTANYL 116 112 S2 20 48
ATORVASTATIN CALCIUM 110 81 21 19
SERTRALINE HCL 108 93 22 23
MIRTAZAPINE 101 73 23 52
TRAMADOL HCL 99 66 24 15
SULFAMETHOXAZOLE-TRIMETHOPRIM 84 58 25 91
FAMOTIDINE 83 73 26 68
BUMETANIDE 81 77 27 70
PROAIR HFA 79 45 28 27
ZOLPIDEM TARTRATE 78 61 29 21
DIGOXIN 77 64 30 71
HYDROCHLOROTHIAZIDE 76 48 31 10
METHADONE HCL 76 12 S2 31 67
TRAZODONE HCL 76 57 31 46
SPIRONOLACTONE 74 47 34 78
RANITIDINE HCL 69 36 35 25
FLUOXETINE HCL 68 23 36 49
NYSTATIN 67 39 37 100
NOVOLOG 66 59 38 89
OLANZAPINE 63 39 39 115
LEVETIRACETAM 63 29 39 96
LOSARTAN POTASSIUM 63 62 39 20
VENLAFAXINE HCL 62 58 42 259
TAMSULOSIN HCL 62 33 42 30
METOPROLOL SUCCINATE 62 58 42 17
CIPROFLOXACIN HCL 61 49 45 59
ALLOPURINOL 57 41 46 35
PREDNISONE 54 40 47 34
NYSTOP 53 33 48 163
CRESTOR 53 32 48 47
OXYBUTYNIN CHLORIDE 53 30 48 92
PAROXETINE HCL 52 39 51 62
ISOSORBIDE MONONITRATE ER 52 37 51 38
LANTUS 52 45 51 40
KLOR-CON M20 52 47 51 86
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 4, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.